14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026
RERE vs ZKH: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 19, 2026, ATRenew Inc. (RERE) is the stronger overall head-to-head candidate over ZKH Group Limited (ZKH) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). RERE carries a Unified Composite Score of 43.4/100 (HOLD) at $4.01 (8.3x Forward P/E, 2.7% operating margin), whereas ZKH carries 48.9/100 (HOLD) at $1.47 (3.3x Forward P/E, -0.8% operating margin).
Composite vs. Pillar Nuance: While ZKH currently prints a higher short-term Unified Composite Score (48.9/100 HOLD vs. RERE 43.4/100 HOLD), RERE captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (2.7% vs. -0.8% operating margin) and revenue trajectory (+32.4% vs. +12.8% YoY).
Technical & Structure Timing Caution: RERE is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.8); meanwhile ZKH is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RERE vs ZKH. Trailing 12-month operating profitability (RERE 2.7% vs ZKH -0.8%) and valuation multiples (RERE 8.3x vs ZKH 3.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Internet Retail value chain with $222.5M market capitalization and -0.8% operating margin.
OpEx & R&D Reinvestment17.4% of Rev ($1.64B)
90D Engineering Disclosures0 Published
Investor FAQ RERE vs ZKH Key Questions & Quantitative Answers
As of Nov 19, 2026, ATRenew Inc. (RERE) is the stronger overall head-to-head candidate over ZKH Group Limited (ZKH) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). RERE carries a Unified Composite Score of 43.4/100 (HOLD) at $4.01 (8.3x Forward P/E, 2.7% operating margin), whereas ZKH carries 48.9/100 (HOLD) at $1.47 (3.3x Forward P/E, -0.8% operating margin). Composite vs. Pillar Nuance: While ZKH currently prints a higher short-term Unified Composite Score (48.9/100 HOLD vs. RERE 43.4/100 HOLD), RERE captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (2.7% vs. -0.8% operating margin) and revenue trajectory (+32.4% vs. +12.8% YoY). Technical & Structure Timing Caution: RERE is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.8); meanwhile ZKH is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
RERE leads the Growth & Scale pillar: RERE posts +32.4% YoY revenue growth and +81.8% YoY earnings growth on $3.09B TTM revenue (20.7% gross margin, 2.7% operating margin), compared with ZKH at +12.8% YoY revenue growth and +0.0% YoY earnings growth on $9.44B TTM revenue (16.6% gross margin, -0.8% operating margin). On trailing 12-month operating scale, RERE generates $3.09B in USD-normalized revenue versus $9.44B for ZKH. In operating R&D and SG&A reinvestment, RERE deploys 18.0% of Rev ($555M) (0 90-day corporate R&D disclosures) versus 17.4% of Rev ($1.64B) (0 disclosures) for ZKH.
RERE screens cheaper on headline valuation multiples. RERE trades at 8.3x Forward P/E, 14.2x Trailing P/E, N/M PEG, and 0.3x EV/Revenue (2.9% EBITDA margin), whereas ZKH trades at 3.3x Forward P/E, 28.2x Trailing P/E, N/M PEG, and N/M EV/Revenue (-0.4% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against RERE (12.3% ROE) versus ZKH (-0.1% ROE) capital efficiency.
In options market volatility and institutional positioning, RERE carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.96β · 55% Vol realized risk). By comparison, ZKH carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.20β · 94% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.